{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:51:34Z","timestamp":1785876694852,"version":"3.56.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.intimp.2021.108186","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T14:18:03Z","timestamp":1635171483000},"page":"108186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"PB","title":["A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata"],"prefix":"10.1016","volume":"101","author":[{"given":"Alaa","family":"Al Bazzal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvaneh","family":"Hatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robabeh","family":"Abedini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifa","family":"Etesami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Aryanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Ghandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2021.108186_b0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/ijd.13453","article-title":"Trichoscopic clues for diagnosis of alopecia areata and trichotillomania in Asians","volume":"56","author":"Khunkhet","year":"2017","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.intimp.2021.108186_b0010","first-page":"209","article-title":"Alopecia areata: An update","volume":"23","author":"Amin","year":"2013","journal-title":"J Pakistan Assoc Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2021.108186_b0015","first-page":"42","article-title":"Randomized trial of tacrolimus 0.1% ointment versus triamcinolone acetonide 0.1% paste in the treatment of oral pemphigus vulgaris. Iranian","volume":"15","author":"Mohammad-Javad","year":"2012","journal-title":"J. Dermatol."},{"key":"10.1016\/j.intimp.2021.108186_b0020","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.intimp.2021.107755","article-title":"Rituximab exhibits a better safety profile when used as a first line of treatment for pemphigus vulgaris: A retrospective study","volume":"96","author":"Aryanian","year":"2021","journal-title":"International Immunopharmacology"},{"issue":"Oct","key":"10.1016\/j.intimp.2021.108186_b0025","article-title":"A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata","volume":"99","author":"Ghandi","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2021.108186_b0030","doi-asserted-by":"crossref","unstructured":"Esmaili, Nafiseh MD*,\u2020; Kamyab, Kambiz MD*,\u2020; Hatami, Parvaneh MD*,\u2020; Behrouzifar, Shirin MD*,\u2020; Daneshpazhooh, Maryam MD*,\u2020; Tavakkolpour, Soheil MD*; Goodarzi, Azadeh MD\u2021; Mortazavi, Hossein MD*,\u2020; Aryanian, Zeinab MD*,\u00a7 Punctate Pattern and Pemphigus, The American Journal of Dermatopathology: August 23, 2021 - Volume - Issue -doi: 10.1097\/DAD.0000000000002047.","DOI":"10.1097\/DAD.0000000000002047"},{"issue":"1","key":"10.1016\/j.intimp.2021.108186_b0035","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.34172\/jlms.2021.21","article-title":"Effect of different pulse durations on the efficacy of long-pulsed alexandrite-assisted hair removal; a split-face comparison study","volume":"12","author":"Noormohammadpour","year":"2021","journal-title":"J Lasers Med Sci."},{"issue":"9","key":"10.1016\/j.intimp.2021.108186_b0040","article-title":"Influence of Narrow-band UVB Phototherapy on Homocysteine Status: A Prospective Study of Patients with Different Cutaneous Disorders","volume":"39","author":"Aryanian","year":"2021","journal-title":"Photomed Laser Surg."},{"key":"10.1016\/j.intimp.2021.108186_b0045","doi-asserted-by":"crossref","unstructured":"Pratt CH, King LE Jr, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3 (1):17011. doi:10.1038\/nrdp.2017.11.","DOI":"10.1038\/nrdp.2017.11"},{"issue":"3","key":"10.1016\/j.intimp.2021.108186_b0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/14656566.2020.1854728","article-title":"Are drug treatment strategies really effective against alopecia areata?","volume":"22","author":"Rattananukrom","year":"2020","journal-title":"Expert Opin Pharmacother."},{"key":"10.1016\/j.intimp.2021.108186_b0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/DER.0000000000000094","article-title":"Treatment of alopecia areata with topical sensitizers","volume":"26","author":"Sutherland","year":"2015","journal-title":"Dermatitis"},{"key":"10.1016\/j.intimp.2021.108186_b0060","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2147\/DDDT.S297858","article-title":"Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update","volume":"Volume 15","author":"Mahasaksiri","year":"2021","journal-title":"Drug design, development and therapy"},{"issue":"2","key":"10.1016\/j.intimp.2021.108186_b0065","doi-asserted-by":"crossref","DOI":"10.4081\/dr.2017.7399","article-title":"A retrospective comparative study of the efficacy and safety of two regimens of diphenylcyclopropenone in the treatment of recalcitrant alopecia areata","volume":"9","author":"Sriphojanart","year":"2017","journal-title":"Dermatology reports"},{"key":"10.1016\/j.intimp.2021.108186_b0070","doi-asserted-by":"crossref","unstructured":"Tosti A., Bellavista S., Iorizzo M. Alopecia areata: a long-term follow-up study of 191 patients. J Am Acad Dermatol. 2006;55:438\u2013441. [PubMed] [Google Scholar].","DOI":"10.1016\/j.jaad.2006.05.008"},{"key":"10.1016\/j.intimp.2021.108186_b0075","doi-asserted-by":"crossref","unstructured":"Olsen E.A., Hordinsky M.K., Price V.H., Roberts J.L., Shapiro J., Canfield D. Alopecia areata investigational assessment guidelines \u2013 Part II. National Alopecia Areata Foundation. J Am Acad Dermatol. 2004;51:440\u2013447. [PubMed] [Google Scholar].","DOI":"10.1016\/j.jaad.2003.09.032"},{"key":"10.1016\/j.intimp.2021.108186_b0080","doi-asserted-by":"crossref","unstructured":"Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part II. Treatment. Journal of the American Academy of Dermatology. 2010;62(2):191-202, quiz 3-4.","DOI":"10.1016\/j.jaad.2009.10.031"},{"issue":"3","key":"10.1016\/j.intimp.2021.108186_b0085","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1468-3083.2004.01138.x","article-title":"Topical immunotherapy with diphencyprone in the treatment of extensive and\/or long-lasting alopecia areata","volume":"19","author":"Firooz","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.intimp.2021.108186_b0090","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1468-3083.2007.02411.x","article-title":"Alopecia areata: topical immunotherapy treatment with diphencyprone","volume":"22","author":"Avgerinou","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.intimp.2021.108186_b0095","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1468-3083.2011.04114.x","article-title":"Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata\u2013a large retrospective study on 142 patients with a self-controlled design","volume":"26","author":"Ohlmeier","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.intimp.2021.108186_b0100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jaad.2017.03.015","article-title":"Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata","volume":"77","author":"Jang","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.intimp.2021.108186_b0105","first-page":"86","article-title":"Multi-Concentration Level Patch Test Guided Diphenyl Cyclopropenone (DPCP) Treatment in Alopecia Totalis or Alopecia Universalis","volume":"100","author":"Thuangtong","year":"2017","journal-title":"J. Med. Ass. of Thailand = Chotmaihet thangphaet."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921008225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921008225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:36:24Z","timestamp":1761586584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921008225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":21,"alternative-id":["S1567576921008225"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108186","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108186"}}